VIA
ACGN

Vident Investment Advisory’s Aceragen Inc ACGN Stock Holding History

Vident Investment Advisory’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,471
Closed -$1.58M – 987
2018
Q1 		$1.58M Buy
6,471
+1,758
+37% +$482K 0.06% 336
2017
Q4 		$1.35M Buy
+4,713
New +$1.35M 0.06% 325

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vident Investment Advisory's ACGN Position: Q2 2018 in Review

Vident Investment Advisory sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 6,471 shares — an estimated $1.58M sold.

Vident Investment Advisory first reported a position in ACGN in Q4 2017 and held it in 2 quarters. The position peaked at $1.58M in Q1 2018. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

  • Vident Investment Advisory reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
  • Vident Investment Advisory sold 6,471 Aceragen Inc shares in Q2 2018, an estimated $1.58M.
  • Vident Investment Advisory first reported a position in Aceragen Inc in Q4 2017 and held it in 2 quarters.
  • Vident Investment Advisory's Aceragen Inc position peaked at $1.58M in Q1 2018.
  • 93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.